Market Overview

Pernix Therapeutics Soars 75% Following Report of 5.8% Stake by Point 72


Shares of Pernix Therapeutics Holdings Inc (NASDAQ: PTX), a nano-cap specialty pharmaceutical company that focuses on products that addresses unmet medical needs, soared higher by more than 75 percent early Monday morning.

Investors and traders were reacting to Point72 Asset Management's disclosure on Friday that it has acquired a 5.8 percent stake in the company.

Point72 Asset Management is a notable asset manager founded by billionaire investor Steven Cohen.

Shares traded recently at $1.29, up 72 percent in the pre-market session.

Posted-In: Pernix Therapeutics Point72 Asset Management Steven Cohen Therapeutics StocksNews Hedge Funds Movers General


Related Articles (PTX)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Oracle Buys Opower For $532 Million

Goldman Reinstates TerraForm Power At Neutral, But Is Selling TerraForm Global